MAPT and Alzheimer disease: In addition to formation and deposition of Aβ and hyperphosphorylated tau, several other molecular alterations have been described in AD, including neuronal dystrophy, synaptic loss, oxidative stress, inflammation, and depletion of acetylcholine (ACh) levels, among many others [5].